Loading…

Impact of the Use of Transradial Versus Transfemoral Approach as Secondary Access in Transcatheter Aortic Valve Implantation Procedures

No data exist on the impact of vascular complications related to the secondary access site in transcatheter aortic valve implantation (TAVI). The objectives of this nonrandomized study were to determine the rate of vascular complications related to the secondary access site in TAVI procedures and to...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2014-12, Vol.114 (11), p.1729-1734
Main Authors: Allende, Ricardo, MD, Urena, Marina, MD, Cordoba, Juan G., MD, Ribeiro, Henrique Barbosa, MD, Amat-Santos, Ignacio, MD, DeLarochellière, Robert, MD, Paradis, Jean-Michel, MD, Doyle, Daniel, MD, Mohammadi, Siamak, MD, Côté, Mélanie, MSc, Abdul-Jawad, Omar, MD, del Trigo, Maria, MD, Ortas, María Rosario, MD, Laflamme, Louis, MS, Laflamme, Jerôme, MS, DeLarochellière, Hugo, MD, Dumont, Eric, MD, Rodés-Cabau, Josep, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:No data exist on the impact of vascular complications related to the secondary access site in transcatheter aortic valve implantation (TAVI). The objectives of this nonrandomized study were to determine the rate of vascular complications related to the secondary access site in TAVI procedures and to evaluate the clinical impact of using the radial versus femoral approach as a secondary access in such procedures. A total of 462 consecutive patients (mean age 79 ± 9 years, 50% men) who underwent TAVI were included. The femoral approach (FA) was used as the secondary access (for the insertion of a 5F pigtail catheter) in 335 patients and the radial approach (RA) in 127 patients. Thirty-day events were prospectively collected. There were no baseline differences between groups, except for a higher prevalence of women and peripheral disease in the FA group (p
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2014.09.009